KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Other financing activities (2016 - 2026)

Encompass Health (EHC) has disclosed Other financing activities for 18 consecutive years, with -$11.9 million as the latest value for Q1 2026.

  • For Q1 2026, Other financing activities fell 56.58% year-over-year to -$11.9 million; the TTM value through Mar 2026 reached -$7.1 million, down 105.1%, while the annual FY2025 figure was -$2.8 million, 101.99% down from the prior year.
  • Other financing activities hit -$11.9 million in Q1 2026 for Encompass Health, down from -$2.8 million in the prior quarter.
  • Across five years, Other financing activities topped out at $138.2 million in Q4 2024 and bottomed at -$31.1 million in Q3 2024.
  • Average Other financing activities over 5 years is $14.6 million, with a median of $8.0 million recorded in 2023.
  • On a YoY basis, Other financing activities climbed as much as 916.18% in 2024 and fell as far as 470.24% in 2024.
  • Encompass Health's Other financing activities stood at $9.0 million in 2022, then skyrocketed by 51.11% to $13.6 million in 2023, then surged by 916.18% to $138.2 million in 2024, then plummeted by 102.03% to -$2.8 million in 2025, then tumbled by 325.0% to -$11.9 million in 2026.
  • According to Business Quant data, Other financing activities over the past three periods came in at -$11.9 million, -$2.8 million, and $7.6 million for Q1 2026, Q4 2025, and Q2 2025 respectively.